PE20120122A1 - Composicion farmaceutica que comprende un analgesico y vitaminas - Google Patents

Composicion farmaceutica que comprende un analgesico y vitaminas

Info

Publication number
PE20120122A1
PE20120122A1 PE2011001166A PE2011001166A PE20120122A1 PE 20120122 A1 PE20120122 A1 PE 20120122A1 PE 2011001166 A PE2011001166 A PE 2011001166A PE 2011001166 A PE2011001166 A PE 2011001166A PE 20120122 A1 PE20120122 A1 PE 20120122A1
Authority
PE
Peru
Prior art keywords
vitamin
solution
pharmaceutical composition
analgesic
vitamins
Prior art date
Application number
PE2011001166A
Other languages
English (en)
Inventor
Lopez Enrique Raul Garcia-Salgado
Hernandez Gustavo Barranco
Original Assignee
Senosiain S A De C V Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from MXPA/A/2006/004020A external-priority patent/MXPA06004020A/es
Application filed by Senosiain S A De C V Lab filed Critical Senosiain S A De C V Lab
Publication of PE20120122A1 publication Critical patent/PE20120122A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE: (A) UNA SAL DE KETOROLACO QUE COMPRENDE KETOROLACO TROMETAMINA EN CANTIDAD DE 2-30 mg QUE SE ENCUENTRA EN UNA UNIDAD DE SOLUCION ENTRE 0.25% -3.0%; (B) UN AGENTE PARA AJUSTAR EL PH DE LA SOLUCION ANTERIOR, AMORTIGUADORES, AGUA Y ALCOHOL ETILICO DONDE EL PH DE LA SOLUCION ES DE 7.5 A 9.5; (C) UNA UNIDAD DE SOLUCION DE VITAMINAS DEL COMPLEJO B QUE COMPRENDE: 15 A 250 mg O 0.25 A 15% DE VITAMINA B1 Y/O 15 A 250mg O 0.25-15% DE VITAMINA B6 Y/O 0.2-2% DE VITAMINA B12; (D) CONSERVADORES SELECCIONADOS DEL GRUPO DE PARABENOS O CUALQUIER OTRO PERMITIDO EN SOLUCIONES PARENTERALES. LA COMPOSICION COMPRENDE DOS UNIDADES DE SOLUCIONES PARENTERALES Y LA MEZCLA DE LAS MISMAS PRESENTA UN PH DE 3.5 A 5.5. DICHA COMPOSICION ES ESTABLE, SEGURA Y EFICAZ SIENDO UTIL EN EL TRATAMIENTO DEL DOLOR
PE2011001166A 2006-04-10 2007-04-09 Composicion farmaceutica que comprende un analgesico y vitaminas PE20120122A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MXPA/A/2006/004020A MXPA06004020A (es) 2006-04-10 Composicion farmaceutica que comprende un analgesico y vitaminas

Publications (1)

Publication Number Publication Date
PE20120122A1 true PE20120122A1 (es) 2012-03-09

Family

ID=38580737

Family Applications (2)

Application Number Title Priority Date Filing Date
PE2011001166A PE20120122A1 (es) 2006-04-10 2007-04-09 Composicion farmaceutica que comprende un analgesico y vitaminas
PE2007000424A PE20080363A1 (es) 2006-04-10 2007-04-09 Composicion farmaceutica que comprende ketorolaco y complejo b

Family Applications After (1)

Application Number Title Priority Date Filing Date
PE2007000424A PE20080363A1 (es) 2006-04-10 2007-04-09 Composicion farmaceutica que comprende ketorolaco y complejo b

Country Status (16)

Country Link
US (1) US20090227534A1 (es)
EP (1) EP2008655B1 (es)
JP (1) JP5244089B2 (es)
AR (1) AR060394A1 (es)
BR (1) BRPI0709967A2 (es)
CA (1) CA2649194C (es)
CO (1) CO6331430A2 (es)
CR (1) CR10360A (es)
DO (1) DOP2007000055A (es)
EC (1) ECSP088801A (es)
ES (1) ES2428342T3 (es)
GT (1) GT200800208A (es)
HN (1) HN2008001531A (es)
PE (2) PE20120122A1 (es)
PL (1) PL2008655T3 (es)
WO (1) WO2007116287A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008003230A (es) * 2008-03-07 2009-09-07 Senosiain S A De C V Lab Composicion famaceutica oral que comprende la combinacion de una sal de ketorolaco y vitaminas del complejo b.
ES2753981T3 (es) * 2010-10-21 2020-04-15 Rtu Pharmaceuticals Llc Formulaciones de ketorolaco listas para uso
AU2013201465B2 (en) * 2012-10-24 2016-03-03 Rayner Surgical (Ireland) Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
TWI705812B (zh) 2014-12-01 2020-10-01 奥默羅斯公司 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2823167A (en) * 1955-03-29 1958-02-11 Vitarine Co Inc Stable vitamin b12-containing solution
FR4492M (es) * 1965-07-07 1966-10-10
US4579846A (en) * 1984-10-11 1986-04-01 Pfizer Inc. Antiinflammatory compositions and methods
US6051587A (en) 1998-04-16 2000-04-18 Medicure, Inc. Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein
US20030191187A1 (en) * 2002-04-01 2003-10-09 Lee Fang Yu Injectable pharmaceutical composition containing a non-steroidal anti-inflammatory drug and method for preparing the same
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
MXPA02010828A (es) 2002-11-04 2004-07-16 Leopoldo Espinosa Abdala Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.

Also Published As

Publication number Publication date
JP5244089B2 (ja) 2013-07-24
BRPI0709967A2 (pt) 2011-08-02
CO6331430A2 (es) 2011-10-20
ES2428342T3 (es) 2013-11-07
EP2008655A1 (en) 2008-12-31
CA2649194C (en) 2014-12-30
HN2008001531A (es) 2011-07-12
JP2009533413A (ja) 2009-09-17
GT200800208A (es) 2010-03-18
ECSP088801A (es) 2009-01-30
AR060394A1 (es) 2008-06-11
WO2007116287A1 (es) 2007-10-18
CA2649194A1 (en) 2007-10-18
PL2008655T3 (pl) 2013-11-29
DOP2007000055A (es) 2007-10-31
EP2008655B1 (en) 2013-06-26
US20090227534A1 (en) 2009-09-10
PE20080363A1 (es) 2008-05-25
CR10360A (es) 2009-02-20

Similar Documents

Publication Publication Date Title
HRP20121072T1 (hr) Postupci za davanje tetrahidrobiopterina, povezani pripravci i postupci mjerenja
US20060233892A1 (en) Topiramate compositions for treatment of headache
EP2444072A3 (en) Non-mucoadhesive film dosage forms
MA33044B1 (fr) Composition pharmaceutique contenant des derives de glucopyranosyl diphenylmethane, sa forme posologique galenique, son procede de preparation et ses utilisations pour une regulation glycemique amelioree chez un patient
BR9908121A (pt) Forma galênica de liberação imediata e de liberação prolongada administrável por via oral compreendendo um agente estimulador de absorção e utilização deste agente estimulador de absorção
EA200602294A1 (ru) Жевательная таблетка, таблетка для рассасывания и таблетка для глотания, содержащая кальцийсодержащее соединение в качестве активного вещества
PE20110711A1 (es) Tratamiento de trastornos cognitivos con (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y sales farmaceuticamente aceptables de la misma
EA200801826A1 (ru) Дейтерированные производные катехоламина и лекарственные средства, содержащие указанные соединения
BRPI0513673B8 (pt) método para produzir um medicamento para aumentar a eficácia e o transporte dos compostos biologicamente ativos enteralmente administrados, e composição farmacêutica
AR062167A1 (es) Sistema de administracion gastrorretentivo
ES2720954T3 (es) Formulaciones estabilizadas de estatina
EA201300314A8 (ru) Композиции и лекарственное средство для лечения глазных болезней, устройство, содержащее композиции и лекарственное средство
PE20120122A1 (es) Composicion farmaceutica que comprende un analgesico y vitaminas
RU2015109566A (ru) НОВЫЕ ЭКСТРАКТЫ ИЗ CYNARA SCOLYMUS, COFFEA spp. И OLEA EUROPAEA ДЛЯ ЛЕЧЕНИЯ МЕТАБОЛИЧЕСКОГО СИНДРОМА
BR0308229A (pt) Medicamentos contendo ingredientes ativos que diminuem o nìvel de colesterol com liberação do ingrediente ativo de tempo tardio
AR026254A1 (es) El uso de una preparacion de liberacion controlada para la preparacion de un medicamento para aumentar la dosis o la exposicion sistemica de un farmaco queinhibe la fosfodiesterasa 4
BR0008057A (pt) Forma cristalina de eplerenona apresentando velocidade de dissolução intensificada
WO2001081328A3 (en) Thiazolidinedione analogues and their use for the treatment of diabetes
BRPI0410374A (pt) composição farmacêutica que compreende valsartano
BR112015018144A8 (pt) composição de emulsão água/óleo farmacêutica estável com gotículas de óleo manométricas, método para fazer a mesma e alta dose única de clopidogrel usada para tratar um paciente
Howick Escaping from placebo prison
AR045070A1 (es) Preparados farmaceuticos topicos de acido ascorbico con efecto post-antimicotico
KR890007728A (ko) 진통제 제조방법
AR044697A1 (es) Formulaciones farmaceuticas que comprenden amoxicilina y clavulanato
JP2019511996A5 (es)

Legal Events

Date Code Title Description
FG Grant, registration